Andrew C Steer Selected Research

Impetigo (Impetigo Contagiosa)

9/2022	Mass Drug Administration for the Control of Scabies: A Systematic Review and Meta-analysis.
5/2022	Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020.
3/2021	Prevalence of scabies and impetigo in school-age children in Timor-Leste.
10/2020	Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin.
1/2020	Longitudinal Analysis of Group A Streptococcus emm Types and emm Clusters in a High-Prevalence Setting: Relationship between Past and Future Infections.
1/2019	Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo.
1/2019	Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.
11/2017	Clinical development strategy for a candidate group A streptococcal vaccine.
12/2015	Mass Drug Administration for Scabies Control in a Population with Endemic Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew C Steer Research Topics

Disease

21	Scabies (Sarcoptic Mange) 09/2022 - 04/2013
20	Infections 05/2022 - 06/2006
13	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2022 - 02/2008
9	Impetigo (Impetigo Contagiosa) 09/2022 - 12/2015
9	Filarial Elephantiasis (Lymphatic Filariasis) 05/2022 - 04/2013
8	Pharyngitis (Sore Throat) 05/2021 - 12/2009
6	Neglected Diseases 01/2022 - 10/2018
5	Rheumatic Fever (Acute Articular Rheumatism) 01/2020 - 12/2009
4	Streptococcal Infections (Streptococcal Infection) 01/2019 - 03/2008
3	COVID-19 01/2022 - 01/2021
3	Communicable Diseases (Infectious Diseases) 01/2019 - 01/2015
2	Disease Progression 01/2022 - 06/2012
2	Body Weight (Weight, Body) 12/2020 - 01/2018
2	Trachoma 01/2019 - 10/2018
2	Skin Diseases (Skin Disease) 01/2019 - 11/2016
1	Soft Tissue Infections 05/2022
1	Reinfection 01/2021
1	Larva Migrans (Cutaneous Larva Migrans) 01/2021
1	Trichuriasis 01/2021
1	Strongyloidiasis 01/2021
1	Myiasis (Myiases) 01/2021
1	Parasitic Diseases (Parasitic Disease) 01/2021
1	Meningococcal Infections 03/2019
1	Empyema 01/2019
1	Abscess 01/2019
1	Filariasis 01/2019
1	Furunculosis (Boils) 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2016
1	Tuberculosis (Tuberculoses) 01/2016
1	Malaria 02/2013
1	Necrotizing Fasciitis 06/2012
1	Septic Shock (Toxic Shock Syndrome) 06/2012
1	Fasciitis (Fascitis) 03/2008
1	Cerebellar Ataxia (Dysmetria) 06/2006
1	Ophthalmoplegia (External Ophthalmoplegia) 06/2006
1	Brain Diseases (Brain Disorder) 06/2006
1	Ataxia (Dyssynergia) 06/2006
1	Encephalitis (Encephalitis, Rasmussen) 06/2006

Drug/Important Bio-Agent (IBA)

19	Ivermectin (Mectizan)FDA Link 05/2022 - 04/2013
17	VaccinesIBA 01/2022 - 12/2009
6	Albendazole (Albenza)FDA Link 05/2022 - 01/2020
6	Diethylcarbamazine (Hetrazan)FDA Link 05/2022 - 01/2020
6	Pharmaceutical PreparationsIBA 01/2021 - 10/2018
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 03/2008
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2013
4	Permethrin (Ambush)FDA LinkGeneric 05/2022 - 12/2015
4	Azithromycin (Zithromax)FDA LinkGeneric 10/2020 - 10/2018
3	Clindamycin (Cleocin)FDA LinkGeneric 01/2019 - 01/2011
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017 - 03/2008
2	AntibodiesIBA 12/2020 - 06/2006
2	AntigensIBA 01/2019 - 04/2013
2	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2019 - 01/2011
2	Penicillins (Penicillin)FDA Link 12/2009 - 02/2008
1	insulin receptor-related receptor (IRR)IBA 05/2022
1	mRNA VaccinesIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2021
1	InterferonsIBA 01/2021
1	P-30 composite resin (P 30)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	streptolysin OIBA 01/2021
1	deoxyribonuclease BIBA 01/2021
1	CytokinesIBA 01/2021
1	TabletsIBA 12/2020
1	Antiparasitic Agents (Antiparasitics)IBA 12/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Linezolid (Zyvox)FDA Link 01/2019
1	Vancomycin FDA LinkGeneric 01/2019
1	Tetracycline (Achromycin)FDA LinkGeneric 10/2018
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 11/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	Combined VaccinesIBA 04/2013
1	Chloroquine (Aralen)FDA LinkGeneric 02/2013
1	Quinine (Quinson)FDA Link 02/2013
1	ArtesunateIBA 02/2013
1	artemisinin (artemisinine)IBA 02/2013
1	SuperantigensIBA 06/2012
1	Virulence Factors (Pathogenicity Factors)IBA 06/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2009
1	beta-Lactamases (beta-Lactamase)IBA 08/2009

Therapy/Procedure

23	Mass Drug Administration 09/2022 - 04/2013
5	Antibiotic Prophylaxis 01/2022 - 01/2016
4	Therapeutics 01/2016 - 06/2012
3	Secondary Prevention 01/2017 - 12/2009
2	Drug Therapy (Chemotherapy) 03/2022 - 01/2020
2	Debridement 06/2012 - 03/2008
1	Duration of Therapy 01/2019
1	Resuscitation 01/2017
1	Critical Care (Surgical Intensive Care) 06/2012